期刊文献+

泛肽—蛋白酶体对TRAIL诱导凋亡作用的影响 被引量:1

Effect of ubiquitin-proteasome pathway on TRAIL inducing apoptosis
暂未订购
导出
摘要 目的 :探讨泛肽 蛋白酶体对TRAIL诱导细胞凋亡作用的影响。方法 :对四种不同处理组 (PBS ;anti DR5 ;lactacystin和anti DR5加lactacystin)的RSAF细胞及SCID小鼠滑囊细胞分别用Hoechst 33342染色和TUNEL染色后 ,检测其细胞凋亡率。用Hoechst染色和LuminescentATPLite法定量分析Caspase抑制剂对细胞凋亡的影响。结果 :Lactacystin阻断泛肽 蛋白酶体通路后 ,Anti DR5与TRAILR2结合后能诱导 95 %以上的RASF细胞出现凋亡。而分别用anti DR5抗体和lactacystin单独处理的细胞却没有观察到这种现象。结论 :泛肽 蛋白酶体通路参与了对TRAIL诱导的细胞凋亡的调节。而Caspase 8和Caspase 4的激活在泛肽 Objective To determine the influence of ubiquitin-proteasome in regulating the TRAIL-mediated apoptosis.Methods RASF cells and SCID mice were divided into 4 groups treated with PBS,anti-DR5,lactacystin,and anti-DR5 plus lactacystin. The apoptosis of cells was detected with Hoechst 33342 and TUNEL. The effect of caspase inhibitor on cell apoptosis was analysed with Hoechst 33342 and Luminescent ATP Lite.Results Block ubiquitin-proteasome with lactacystin , a highly specific and irreversible proteasome inhibitor, induced 95% cell apoptosis both in vitro and in vivo. In contrast, there was no apoptosis of cells after the treatment with anti-DR5 antibody or lactacystin alone. Conclusion The inhibition of ubiquitin-proteasome pathway can sensitize rheumatoid arthritis synovial fibroblast cells to TRAIL- induced apoptosis, and the activation of caspase 8 and caspase 4 is necessary in this process.
作者 杨新文
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2004年第1期54-57,共4页 Journal of Central South University :Medical Science
关键词 泛肽-蛋白酶体 细胞凋亡 信号传导 肿瘤细胞 肿瘤生物学 ubiquitin-proteasome TRAIL apoptosis
  • 相关文献

参考文献12

  • 1Wiley SR,Schooley K,Smolak PJ,et al.Identification and characterization of a new member of the TNF family that induces apoptosis[J].Immunity,1995,3(6):673-682.
  • 2Srivastava RK.TRAIL/Apo-2L:mechanisms and clinical applications in cancer[J].Neoplasia(New York),2001,3(6):535-546.
  • 3King RW.How proteolysis drives the cell cycle[J].Science,1996,274(5293):1652-1659.
  • 4Maki C G,Huibregse J M,Howley P M.In vivo ubiquitination and proteasome mediated degradation of P53[J].Cancer Res,1996,56(11):2649-2654.
  • 5Pan G,O'Rourke K,Chinnaiyan AM,et al.The receptor for the cytotoxic ligand TRAIL[J].Science,1997,276(5309):111-113.
  • 6Griffith TS,Lynch DH.TRAIL:a molecule with multiple receptors and control mechanisms[J].Curr Opin Immunol,1998,10(5):559-563.
  • 7Griffith TS,Rauch CT,Smolak PJ,et al.Functional analysis of TRAIL receptors using monoclonal antibodies[J].J Immunol,1999,162(5):2597-2605.
  • 8Degli-Esposti MA,Dougall WC,Smolak PJ,et al.The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis,yet retains an incomplete death domain[J].Immunity,1997,7(6):813-820.
  • 9Griffith TS,Chin WA,Jackson GC,et al.Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells[J].J Immunol,1998,161(6):2833-2840.
  • 10Yeh WC,Pompa JL,McCurrach ME,et al.FADD:essential for embryo development and signaling from some,but not all,inducers of apoptosis[J].Science,1998,279(5358):1954-1958.

同被引文献46

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部